Invesco
RUBY

Invesco’s Rubius Therapeutics, Inc RUBY Stock Holding History

Invesco’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,047
Closed -$116K – 4198
2022
Q1 		$116K Buy
21,047
+377
+2% +$2.39K ﹤0.01% 3857
2021
Q4 		$199K Sell
20,670
-4,807
-19% -$66.7K ﹤0.01% 3785
2021
Q3 		$455K Buy
25,477
+3,791
+17% +$82.5K ﹤0.01% 3477
2021
Q2 		$530K Buy
21,686
+12,125
+127% +$303K ﹤0.01% 3392
2021
Q1 		$253K Sell
9,561
-16,150
-63% -$236K ﹤0.01% 3611
2020
Q4 		$195K Buy
25,711
+5,192
+25% +$30.8K ﹤0.01% 3539
2020
Q3 		$102K Sell
20,519
-501
-2% -$2.65K ﹤0.01% 3576
2020
Q2 		$126K Sell
21,020
-2,148
-9% -$12.7K ﹤0.01% 3564
2020
Q1 		$103K Sell
23,168
-356,038
-94% -$2.64M ﹤0.01% 3563
2019
Q4 		$3.6M Hold
379,206
– – ﹤0.01% 2350
2019
Q3 		$2.98M Hold
379,206
– – ﹤0.01% 2417
2019
Q2 		$5.96M Buy
379,206
+25
+0% +$403 ﹤0.01% 2073
2019
Q1 		$6.86M Sell
379,181
-324
-0.1% -$4.97K ﹤0.01% 1798
2018
Q4 		$6.1M Sell
379,505
-2,397
-0.6% -$43.7K ﹤0.01% 1819
2018
Q3 		$9.17M Buy
+381,902
New +$8.73M ﹤0.01% 1764

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco's RUBY Position: Q2 2022 in Review

Invesco sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 21,047 shares — an estimated $116K sold.

Invesco first reported a position in RUBY in Q3 2018 and held it in 15 quarters. The position peaked at $9.17M in Q3 2018. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Invesco reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 21,047 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $116K.
  • Invesco first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 15 quarters.
  • Invesco's Rubius Therapeutics, Inc position peaked at $9.17M in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.